Apricus Biosciences Inc., of San Diego, said it entered a common stock purchase agreement with Aspire Capital Fund LLC, which is purchasing 1,159,824 shares of common stock for $2 million upon execution of the agreement and they have committed to purchase up to $20 million of additional shares of common stock over the next 24 months at prices based on the market price at the time of each sale.